Merck Limited, a prominent player in the biopharma, performance materials, and life sciences sectors, is headquartered in India. Established in 1668, the company has evolved significantly, marking key milestones in innovation and market expansion. With a strong presence in Asia and beyond, Merck Limited is renowned for its cutting-edge solutions in pharmaceuticals, biotechnology, and advanced materials. The company’s core offerings include biopharmaceuticals, laboratory supplies, and high-performance materials, distinguished by their commitment to quality and sustainability. Merck Limited has consistently maintained a strong market position, recognised for its contributions to scientific research and development. As a trusted partner in the life sciences industry, Merck Limited continues to drive advancements that enhance health and well-being globally.
How does Biopharma, Performance Materials and Life Science Segments of Merck Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biopharma, Performance Materials and Life Science Segments of Merck Limited's score of 30 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merck Limited's Biopharma, Performance Materials, and Life Science segments currently do not report specific carbon emissions data, as no emissions figures are available. The organisation is a merged entity, inheriting its climate commitments and targets from its parent company, Merck KGaA, at a cascade level of 3. While specific reduction targets or achievements are not detailed, Merck KGaA has established science-based targets (SBTi) and participates in the Carbon Disclosure Project (CDP), indicating a commitment to transparency and accountability in climate action. These initiatives reflect a broader industry trend towards reducing greenhouse gas emissions and enhancing sustainability practices. As a merged entity, Merck Limited's performance data may also be influenced by EMD Millipore Corporation, which operates at a cascade level of 2. However, without specific emissions data or reduction targets, the focus remains on the overarching commitments inherited from its parent organisation. In summary, while detailed emissions data is currently unavailable, Merck Limited's segments are aligned with the climate initiatives of Merck KGaA, demonstrating a commitment to addressing climate change through inherited strategies and industry standards.
Access structured emissions data, company-specific emission factors, and source documents
2006 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 352,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | - | 000,000,000 |
Scope 2 | 402,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | 000,000,000 |
Scope 3 | - | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biopharma, Performance Materials and Life Science Segments of Merck Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.